Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 32-41, 15 April 2010

The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide

Centro de Estudios Farmacológicos y Botánicos, CEFYBO-CONICET-UBA, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155 piso 16, 1121ABG, Buenos Aires, Argentina

Received 12 January 2010; received in revised form 4 February 2010; accepted 4 February 2010. published online 08 March 2010.

Abstract 

This study investigated the participation of the hypothalamic endocannabinoid system in the response to lipopolysaccharide (LPS) challenge evaluating oxytocin (OXT) and tumor necrosis factor-alpha (TNF-a) plasma levels in vivo and their release from hypothalamic fragments in vitro. LPS increased OXT and TNF-α release through anandamide-activation of hypothalamic cannabinoid receptor CB1, since the antagonist AM251 blocked this effect. Anandamide, through its receptors, also increased hypothalamic nitric oxide (NO) which inhibited OXT release, ending the stimulatory effect of the endocannabinoid. Our findings reveal a hypothalamic interaction between oxytocin, endocannabinoid and NO-ergic systems providing a regulation of the hypothalamic–neurohypophyseal axis under basal and stress conditions.

Keywords: Anandamide, Cannabinoid receptors, Nitric oxide synthase, Cytokines, Hypothalamus

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-5728(10)00055-X

doi:10.1016/j.jneuroim.2010.02.006

Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 32-41, 15 April 2010